Intervacc is trading at €0.08 (-4.14%), with no clear company-specific announcement identified for September 7, 2026; the decline remains unexplained.
- Recent coverage centers on the August 20 interim report and July 30 EMA application for extended Strangvac immunity.
- Major indices were broadly flat, while futures showed mixed, cautious sentiment, offering no strong confirmed market-wide explanation.
- The move may reflect low-liquidity trading.